Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(9), P. 1109 - 1109
Published: Sept. 13, 2024
Oxidative
stress
is
the
result
of
imbalance
between
reactive
oxygen
and
nitrogen
species
(RONS),
which
are
produced
by
several
endogenous
exogenous
processes,
antioxidant
defenses
consisting
molecules
that
protect
biological
systems
from
free
radical
toxicity.
a
major
factor
in
aging
process,
contributing
to
accumulation
cellular
damage
over
time.
biomolecules,
leads
DNA
alterations,
lipid
peroxidation,
protein
oxidation,
mitochondrial
dysfunction
resulting
senescence,
immune
system
tissue
dysfunctions,
increased
susceptibility
age-related
pathologies,
such
as
inflammatory
disorders,
cardiovascular
neurodegenerative
diseases,
diabetes,
cancer.
stress-driven
mutations,
or
methylation
histone
modification,
alter
gene
expression,
key
determinants
tumor
initiation,
angiogenesis,
metastasis,
therapy
resistance.
Accumulation
genetic
epigenetic
damage,
oxidative
contributes,
eventually
unrestrained
cell
proliferation,
inhibition
differentiation,
evasion
death,
providing
favorable
conditions
for
tumorigenesis.
Colorectal,
breast,
lung,
prostate,
skin
cancers
most
frequent
aging-associated
malignancies,
implicated
their
pathogenesis
behavior.
Our
aim
shed
light
on
molecular
mechanisms
link
stress,
aging,
cancers,
highlighting
impact
both
RONS
antioxidants,
provided
diet
exercise,
immunity,
development
an
antitumor
response.
The
dual
role
ROS
physiological
regulators
signaling
responsible
well
its
use
anti-tumor
therapeutic
purposes,
will
also
be
discussed.
Managing
crucial
promoting
healthy
reducing
risk
tumors.
Molecular Cancer,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: July 14, 2022
Abstract
Background
The
Wnt
signaling
pathway
is
a
complex
network
of
protein
interactions
that
functions
most
commonly
in
embryonic
development
and
cancer,
but
also
involved
normal
physiological
processes
adults.
canonical
regulates
cell
pluripotency
determines
the
differentiation
fate
cells
during
development.
(also
known
as
Wnt/β-catenin
pathway)
recognized
driver
colon
cancer
one
representative
pathways.
As
functional
effector
molecule
signaling,
modification
degradation
β-catenin
are
key
events
progression
cancer.
Therefore,
plays
an
important
role
pathogenesis
diseases,
especially
colorectal
(CRC).
Objective
Inhibit
to
explore
therapeutic
targets
Methods
Based
on
studying
pathway,
master
biochemical
related
analyze
relevant
when
drugs
or
inhibitors
act
clarify
medication
ideas
for
treatment
Results
pathways
include:
planar
polarity
(Wnt-PCP)
Wnt-Ca
2+
pathway.
closely
proliferation,
stemness,
apoptosis,
autophagy,
metabolism,
inflammation
immunization,
microenvironment,
resistance,
ion
channel,
heterogeneity,
EMT/migration/invasion/metastasis.
Drugs/phytochemicals
molecular
preparations
CRC
have
now
been
developed.
used
clinically
CRC.
Conclusion
drugs/phytochemicals
targeting
can
effectively
treat
clinically.
Molecular Cancer,
Journal Year:
2020,
Volume and Issue:
19(1)
Published: May 27, 2020
Gastric
cancer
is
a
deadly
disease
and
remains
the
third
leading
cause
of
cancer-related
death
worldwide.
The
5-year
overall
survival
rate
patients
with
early-stage
localized
gastric
more
than
60%,
whereas
that
distant
metastasis
less
5%.
Surgical
resection
best
option
for
cancer,
while
chemotherapy
mainly
used
in
middle
advanced
stages
this
disease,
despite
frequently
reported
treatment
failure
due
to
resistance.
Therefore,
there
an
unmet
medical
need
identifying
new
biomarkers
early
diagnosis
proper
management
patients,
achieve
response
treatment.
Long
non-coding
RNAs
(lncRNAs)
body
fluids
have
attracted
widespread
attention
as
screening,
diagnosis,
treatment,
prognosis,
responses
drugs
high
specificity
sensitivity.
In
present
review,
we
focus
on
clinical
potential
lncRNAs
liquid
biopsies
prognosis
cancer.
We
also
comprehensively
discuss
roles
their
molecular
mechanisms
chemoresistance
well
therapeutic
targets
precision
medicine.
Cancer Communications,
Journal Year:
2021,
Volume and Issue:
41(3), P. 199 - 217
Published: Jan. 27, 2021
Abstract
Epithelial‐to‐mesenchymal
transition
(EMT)
is
implicated
in
a
wide
array
of
malignant
behaviors
cancers,
including
proliferation,
invasion,
and
metastasis.
Most
notably,
previou
studies
have
indicated
that
both
cancer
stem‐like
properties
drug
resistance
were
associated
with
EMT.
Furthermore,
microRNAs
(miRNAs)
play
pivotal
role
the
regulation
EMT
phenotype,
as
result,
some
miRNAs
impact
stemness
resistance.
Therefore,
understanding
relationship
between
EMT‐associated
stemness/drug
beneficial
to
basic
research
clinical
treatment.
In
this
review,
we
preliminarily
looked
into
various
roles
nature
cells.
Then,
reviewed
interaction
drug‐resistant
complex
signaling
pathways
multiple
cancers
lung
cancer,
gastric
gynecologic
breast
liver
colorectal
pancreatic
esophageal
nasopharyngeal
cancer.
We
finally
discussed
EMT,
stemness,
resistance,
well
forward
potential
applications
miRNA
therapy
for
tumors.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(11), P. 4002 - 4002
Published: June 3, 2020
Therapy
resistance
is
a
characteristic
of
cancer
cells
that
significantly
reduces
the
effectiveness
drugs.
Despite
popularity
cisplatin
(CP)
as
chemotherapeutic
agent,
which
widely
used
in
treatment
various
types
cancer,
to
CP
chemotherapy
has
been
extensively
observed.
Among
reported
mechanism(s),
epithelial-mesenchymal
transition
(EMT)
process
can
contribute
chemoresistance
by
converting
motionless
epithelial
into
mobile
mesenchymal
and
altering
cell-cell
adhesion
well
cellular
extracellular
matrix,
leading
invasion
tumor
cells.
By
analyzing
impact
different
molecular
pathways
such
microRNAs,
long
non-coding
RNAs,
nuclear
factor-κB
(NF-ĸB),
phosphoinositide
3-kinase-related
protein
kinase
(PI3K)/Akt,
mammalian
target
rapamycin
(mTOR),
Wnt,
play
an
important
role
exhibited
therapy,
we
first
give
introduction
about
EMT
mechanism
its
drug
resistance.
We
then
focus
specifically
on
involved
pharmacological
strategies
be
mitigate
this
Overall,
highlight
targeted
signaling
could
considered
future
studies
pave
way
for
inhibition
EMT-mediated
displayed
response
exposure.
Frontiers in Oncology,
Journal Year:
2020,
Volume and Issue:
10
Published: Nov. 6, 2020
TP53
is
the
most
frequently
mutated
tumor
suppressor
gene
in
human
cancer.
The
majority
of
mutations
p53
are
missense
mutations,
leading
to
expression
full
length
mutant
proteins.
Mutant
(Mutp53)
proteins
not
only
lose
wild-type
p53-dependent
suppressive
functions,
but
also
acquire
oncogenic
gain-of-functions
(GOF)
that
promote
tumorigenesis.
In
this
review,
we
summarize
recent
advances
our
understanding
GOF
mutp53
and
potential
therapies
targeting
cancers.
particular,
discuss
promising
drugs
currently
under
clinical
trials
as
well
emerging
therapeutic
strategies,
including
CRISPR/Cas9
based
genome
edition
allele,
small
peptide
mediated
restoration
function,
immunotherapies
directly
eliminate
expressing
cells.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(15), P. 5207 - 5207
Published: July 23, 2020
Osteosarcomas
(OSs)
are
bone
tumors
most
commonly
found
in
pediatric
and
adolescent
patients
characterized
by
high
risk
of
metastatic
progression
recurrence
after
therapy.
Effective
therapeutic
management
this
disease
still
remains
elusive
as
evidenced
poor
patient
survival
rates.
To
achieve
a
more
effective
regimen,
hence
survival,
there
is
need
to
identify
focused
targeted
therapies
for
OSs
treatment
the
clinical
setting.
The
role
OS
tumor
stroma
microenvironment
plays
significant
part
development
dissemination
disease.
Important
components,
potential
targets
treatment,
tumor-infiltrating
macrophages
that
known
orchestrate
many
aspects
stromal
signaling
progression.
In
particular,
increased
infiltration
M2-like
tumor-associated
(TAMs)
has
been
associated
with
metastasis
prognosis
despite
currently
used
aggressive
regimens.
This
review
aims
provide
summary
update
current
macrophage-centered
knowledge
discuss
possible
roles
play
process
focusing
on
influence
cross-talk
between
TAMs,
cancer-stem
cells
additional
tumoral
factors.
Cells,
Journal Year:
2020,
Volume and Issue:
9(7), P. 1651 - 1651
Published: July 9, 2020
Radiotherapy
(RT)
is
a
modality
of
oncologic
treatment
that
can
be
used
to
treat
approximately
50%
all
cancer
patients
either
alone
or
in
combination
with
other
modalities
such
as
surgery,
chemotherapy,
immunotherapy,
and
therapeutic
targeting.
Despite
the
technological
advances
RT,
which
allow
more
precise
delivery
radiation
while
progressively
minimizing
impact
on
normal
tissues,
issues
like
radioresistance
tumor
recurrence
remain
important
challenges.
Tumor
heterogeneity
responsible
for
variation
response
different
subpopulations.
A
main
factor
related
presence
stem
cells
(CSC)
inside
tumors,
are
metastases,
relapses,
RT
failure,
poor
prognosis
patients.
The
plasticity
CSCs,
process
highly
dependent
epithelial–mesenchymal
transition
(EMT)
associated
cell
dedifferentiation,
complicates
identification
eradication
CSCs
it
might
involved
disease
relapse
progression
after
irradiation.
microenvironment
interactions
their
niches
also
play
an
role
RT.
This
review
provides
deep
insight
into
characteristics
mechanisms
both
primary
metastasis
radiation,
radiobiological
principles
CSC
Finally,
we
summarize
major
clinical
trials
development
CSC-based
therapies
combined
overcome
radioresistance.
better
understanding
potential
targets
radiosensitization
will
provide
safer
efficient
strategies,
turn
improve
live
expectancy
curability
Cells,
Journal Year:
2019,
Volume and Issue:
8(8), P. 926 - 926
Published: Aug. 18, 2019
Chemoresistance
is
a
major
problem
in
cancer
therapy
as
cells
develop
mechanisms
that
counteract
the
effect
of
chemotherapeutic
compounds,
leading
to
relapse
and
development
more
aggressive
cancers
contribute
poor
prognosis
survival
rates
treated
patients.
Cancer
stem
(CSCs)
play
key
role
this
event.
Apart
from
their
slow
proliferative
property,
CSCs
have
developed
range
cellular
processes
involve
drug
efflux,
enzymatic
inactivation
other
mechanisms.
In
addition,
microenvironment
where
evolve
(CSC
niche),
effectively
contributes
initiation,
progression
chemoresistance.
CSC
niche,
immune
cells,
mesenchymal
(MSCs),
endothelial
associated
fibroblasts
(CAFs)
maintenance
malignancy
via
secretion
factors
promote
resistance
chemotherapy.
Due
these
hinder
successful
therapies,
are
subject
intense
research
aims
at
better
understanding
behaviour
developing
efficient
targeting
therapies.
review,
we
provide
an
overview
chemoresistance,
discuss
progress
has
been
made
targeted